Development of new treatment for severe hemophilia A on track
Lucy Tuffin2019-11-22T11:54:17+00:00BioMarin today announced it has submitted a marketing application to the European Medicines Agency (EMA), for the investigational gene therapy, valoctocogene ro [...]